Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.

Antiviral therapy - 1 Jan 2010

Yeh Chau-Ting

Abstract excerpt

Structurally modified nucleotide/nucleoside analogues can exert potent inhibitory effect on HBV polymerase activities. Some of these agents have been approved for the treatment of chronic hepatitis B. Because of a high risk of reactivation upon drug withdrawal, continuous long-term therapy is rec...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Resistance, Viral
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Nucleosides

Share to Nucleotides

Share to Reverse Transcriptase Inhibitors

Source

Identifiers

PMID: 20516567
DOI: 10.3851/IMP1552

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20516567-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy.PMID 20516567Read ↗

Nucleos(t)ide analogues causes HBV S gene mutations and carcinogenesis.Semantic proximity Read ↗

Hepatitis B Virus (HBV) and S-Escape Mutants: From the Beginning until NowSemantic proximity Read ↗

The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy.Semantic proximity Read ↗

Hepatitis B virus S gene escape mutantsSemantic proximity Read ↗

Small surface antigen variants of HBV associated with responses to telbivudine treatment in chronic hepatitis B patients.Semantic proximity Read ↗

Evolutionary analysis of pre S/S mutations in HBeAg-negative chronic hepatitis B with HBsAg <100 IU/mlSemantic proximity Read ↗

Hepatitis B virus genetic variants: biological properties and clinical implicationsSemantic proximity Read ↗

Hepatitis B virus pre-S/S variants in liver diseases.Semantic proximity Read ↗

Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil.Semantic proximity Read ↗

Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.Semantic proximity Read ↗

Evaluation of the pol/S Gene Overlapping Mutations in Chronic Hepatitis B Patients in Northern Cyprus.Semantic proximity Read ↗

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.